Page 78 - 74_02

GEMMA NAVARRO DÍEZ Y C. TROS DE ILARDUYA AN. R. ACAD. NAC. FARM.

(9) KUKOWSKA-LATALLO, J. F. et al. (2000): Intravascular and endobronchial DNA
delivery to murine lung tissue using a novel, nonviral vector. Human Gene
Ther. 11: 1385-1395.

(10) KIHARA, F. et al. (2003): In vitro and in vivo gene transfer by an optimized
alpha-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug.
Chem. 14: 342-350.

(11) MARUYAMA-TABATA, H. et al. (2000): Effective suicide gene therapy in vivo by
EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene
Ther. 7: 53-60.

(12) RUDOLPH, C. et al. (2000): In vivo gene delivery to the lung using polyethyle-
nimine and fractured polyamidoamine dendrimers. J. Gene Med. 2: 269-278.

(13) HUDDE, T. et al. (1999): Activated polyamidoamine dendrimers, a non-viral
vector for gene transfer to the corneal endothelium. Gene Ther. 6: 939-943.

(14) WANG, Y. et al. (2000): DNA/dendrimer complexes mediate gene transfer into
murine cardiac transplants ex vivo. Mol. Ther. 2: 602-608.

(15) YOO, H. y JULIANO, R. L. (2000): Enhanced delivery of antisense oligonucleo-
tides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res.
28: 4225-4231.

(16) MAMEDE, M. et al. (2004): Hepatocyte targeting of 111 In-labeled oligo-DNA
with avidin or avidin-dendrimer complex. J. Control Release. 95: 133-141.

(17) DUNCAN, R. e IZZO, L. (2005): Dendrimer biocompatibility and toxicity. Adv.
Drug Deliv. Rev. 57: 2215-2237.

(18) BOAS, U. y HEEGAARD, P. M. (2004): Dendrimers in drug research. Chem. Soc.
Rev. 33: 43-63.

(19) FISHER, D. et al. (2003): In vitro cytotoxicity testing of polycations: influence
of polymer structure on cell viability and hemolysis. Biomaterials. 24: 1121-
1131.

(20) ROBERTS, J. C.; BHALGAT, M. K. y ZERA, R. T. (1996): Preliminary biological
evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J. Biomed.
Mater. Res. 30: 53-65.

(21) RAJANANTHANAN, P. et al. (1999): Evaluation of novel aggregate structures as
adjuvants: composition, toxicity studies and humoral responses. Vaccine. 17:
715-730.

(22) KOBAYASHI, H. et al. (2001): Novel liver macromolecular MR contrast agent
with a polypropylenimine diaminobutyl dendrimer core: comparison to the
vascular MR contrast agent with the polyamidoamine dendrimer core. Magn.
Reson. Med. 46: 795-802.

(23) SVENSON, S. y TOMALIA, D. A. (2005): Dendrimers in biomedical applications-
reflections on the field. Adv. Drug Deliv. Rev. 57: 2106-2129.

(24) WADA, K. et al. (2005): Enhancing effects of galactosylated dendrimer/al-
pha-cyclodextrin conjugates on gene transfer efficiency. Biol. Pharm. Bull.
28: 500-505.

(25) KIM, T. I. et al. (2004): PAMAM-PEG-PAMAM: novel triblock copolymer as a
biocompatible and efficient gene delivery carrier. Biomacromolecules. 5: 2487-
2492.

256